NOVEL MORPHOLINYL DERIVATIVES USEFUL AS MOGAT-2 INHIBITORS
申请人:Eli Lilly and Company
公开号:US20150005305A1
公开(公告)日:2015-01-01
The present invention provides compounds of Formula I or a pharmaceutical salt thereof, methods of treating hypertriglyceridemia using the compounds; and a process for preparing the compounds.
Morpholinyl derivatives useful as MOGAT-2 inhibitors
申请人:Eli Lilly and Company
公开号:US08993568B2
公开(公告)日:2015-03-31
The present invention provides compounds of Formula I or a pharmaceutical salt thereof, methods of treating hypertriglyceridemia using the compounds; and a process for preparing the compounds.
本发明提供了I式化合物或其药物盐,使用这些化合物治疗高三酰甘油血症的方法以及制备这些化合物的过程。
URETHANE (METH)ACRYLATE AND MOISTURE-PROOF INSULATING COATING MATERIAL
申请人:SHOWA DENKO K.K.
公开号:US20150005406A1
公开(公告)日:2015-01-01
Provided is a photocurable moisture-proof insulating coating material which places little burden on the environment and has excellent surface curability with low irradiation. In addition, this photocurable moisture-proof insulating coating material is hydrophobic and exhibits high adhesion to a substrate material. Also provided is a novel urethane (meth)acrylate which is used for this moisture-proof insulating coating material. A urethane (meth)acrylate of the present invention is obtained by reacting (a) a polyester polyol that has a structural unit derived from a hydrogenated dimer acid and a structural unit derived from a hydrogenated dimer diol, (b) a polyisocyanate compound and (c) a hydroxyl group-containing (meth)acrylate. A moisture-proof insulating coating material of the present invention contains this urethane (meth)acrylate and a (meth)acryloyl group-containing compound that does not contain a silicon atom.
US8993568B2
申请人:——
公开号:US8993568B2
公开(公告)日:2015-03-31
[EN] NOVEL MORPHOLINYL DERIVATIVES USEFUL AS MOGAT-2 INHIBITORS<br/>[FR] NOUVEAUX DÉRIVÉS MORPHOLYNYLE UTILES COMME INHIBITEURS DE MOGAT-2
申请人:LILLY CO ELI
公开号:WO2013116065A1
公开(公告)日:2013-08-08
The present invention provides compounds of Formula I or a pharmaceutical salt thereof, methods of treating hypertriglyceridemia using the compounds; and a process for preparing the compounds.